The Intriguing Role of Interleukin 13 in the Pathophysiology of Asthma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Intriguing Role of Interleukin 13 in the Pathophysiology of Asthma
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-12-06
DOI
10.3389/fphar.2019.01387
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Innate Immune Modulation by GM-CSF and IL-3 in Health and Disease
- (2019) Francesco Borriello et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Physiological Roles of Mast Cells: Collegium Internationale Allergologicum Update 2019
- (2019) Gilda Varricchi et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Inhibition of IL-13 and IL-13Rα2 Expression by IL-32θ in Human Monocytic Cells Requires PKCδ and STAT3 Association
- (2019) Thu-Huyen Pham et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phenotypes and endotypes of adult asthma: Moving toward precision medicine
- (2019) Ravdeep Kaur et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Role of IL-13Rα2 in modulating IL-13-induced MUC5AC and ciliary changes in healthy and CRSwNP mucosa
- (2018) J. Liu et al. ALLERGY
- Efficacy of an Inhaled Interleukin-13 Antibody Fragment in a Model of Chronic Asthma
- (2018) Daniel Lightwood et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Innate effector cells in angiogenesis and lymphangiogenesis
- (2018) Gilda Varricchi et al. CURRENT OPINION IN IMMUNOLOGY
- Human mast cells and basophils-How are they similar how are they different?
- (2018) Gilda Varricchi et al. IMMUNOLOGICAL REVIEWS
- Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma
- (2018) Klaus F. Rabe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
- (2018) Mario Castro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trial
- (2018) Richard J Russell et al. Lancet Respiratory Medicine
- Tralokinumab for severe, uncontrolled asthma (STRATOS 1 and STRATOS 2): two randomised, double-blind, placebo-controlled, phase 3 clinical trials
- (2018) Reynold A Panettieri et al. Lancet Respiratory Medicine
- Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies
- (2018) J Mark FitzGerald et al. Lancet Respiratory Medicine
- Thymic Stromal Lymphopoietin Isoforms, Inflammatory Disorders, and Cancer
- (2018) Gilda Varricchi et al. Frontiers in Immunology
- Design and characterization of Zweimab and Doppelmab, high affinity dual antagonistic anti-TSLP/IL13 bispecific antibodies
- (2018) Sathyadevi Venkataramani et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Fra2 Overexpression in Mice Leads to Non-allergic Asthma Development in an IL-13 Dependent Manner
- (2018) Anna Gungl et al. Frontiers in Immunology
- Tralokinumab did not demonstrate oral corticosteroid-sparing effects in severe asthma
- (2018) William W. Busse et al. EUROPEAN RESPIRATORY JOURNAL
- Prostaglandin D2 receptor antagonists in allergic disorders: safety, efficacy, and future perspectives
- (2018) Giancarlo Marone et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Type 2 innate lymphoid cells in the induction and resolution of tissue inflammation
- (2018) Antonia Wallrapp et al. IMMUNOLOGICAL REVIEWS
- Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma
- (2018) Sumita Khatri et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Commonality of the IL-4/IL-13 pathway in atopic diseases
- (2017) Namita A. Gandhi et al. Expert Review of Clinical Immunology
- Mast Cells Are Crucial for Induction of Group 2 Innate Lymphoid Cells and Clearance of Helminth Infections
- (2017) Chikako Shimokawa et al. IMMUNITY
- Role of IL-13 Genetic Variants in Signalling of Asthma
- (2017) Madhavi Latha Alasandagutti et al. INFLAMMATION
- Therapeutic efficacy of a co-blockade of IL-13 and IL-25 on airway inflammation and remodeling in a mouse model of asthma
- (2017) Fang-Qi Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Experimental asthma persists in IL-33 receptor knockout mice because of the emergence of thymic stromal lymphopoietin–driven IL-9 + and IL-13 + type 2 innate lymphoid cell subpopulations
- (2017) Mukesh Verma et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Identification of IL-17F/frequent exacerbator endotype in asthma
- (2017) Fabio L.M. Ricciardolo et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Combined blockade of the IL-13 and IL-33 pathways leads to a greater inhibition of type 2 inflammation over inhibition of either pathway alone
- (2017) Vladimir Ramirez-Carrozzi et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Interleukin-13 +2044 G/A and +1923C/T polymorphisms are associated with asthma susceptibility in Asians
- (2017) Quanhui Mei et al. MEDICINE
- Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population
- (2017) Marjan Kerkhof et al. THORAX
- Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?
- (2017) Gilda Varricchi et al. Frontiers in Immunology
- Biologic Therapy and Novel Molecular Targets of Severe Asthma
- (2017) Amber N. Pepper et al. Journal of Allergy and Clinical Immunology-In Practice
- Eosinophils: The unsung heroes in cancer?
- (2017) Gilda Varricchi et al. OncoImmunology
- Protein phosphatase 5 mediates corticosteroid insensitivity in airway smooth muscle in patients with severe asthma
- (2016) L. Chachi et al. ALLERGY
- IL-13+ Type 2 Innate Lymphoid Cells Correlate with Asthma Control Status and Treatment Response
- (2016) Yi Jia et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil Levels
- (2016) Leif Bjermer et al. CHEST
- Severe or life-threatening asthma exacerbation: patient heterogeneity identified by cluster analysis
- (2016) K. Sekiya et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria
- (2016) M. Hew et al. CLINICAL AND EXPERIMENTAL ALLERGY
- A Critical Evaluation of Anti-IL-13 and Anti-IL-4 Strategies in Severe Asthma
- (2016) Diego Bagnasco et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis
- (2016) Claus Bachert et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Role of IL-4 receptor α–positive CD4 + T cells in chronic airway hyperresponsiveness
- (2016) Frank Kirstein et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Rhinovirus infection interferes with induction of tolerance to aeroantigens through OX40 ligand, thymic stromal lymphopoietin, and IL-33
- (2016) Amit K. Mehta et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Multidimensional endotyping in patients with severe asthma reveals inflammatory heterogeneity in matrix metalloproteinases and chitinase 3–like protein 1
- (2016) Timothy S.C. Hinks et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
- (2016) J Mark FitzGerald et al. LANCET
- IL-13/STAT6 signaling plays a critical role in the epithelial-mesenchymal transition of colorectal cancer cells
- (2016) Hui Cao et al. Oncotarget
- Release of Type 2 Cytokines by Epithelial Cells of Nasal Polyps
- (2016) Monica Boita et al. Journal of Immunology Research
- Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials
- (2016) Nicola A Hanania et al. Lancet Respiratory Medicine
- Commentary: IL-4 and IL-13 receptors and signaling
- (2015) Sarah M. McCormick et al. CYTOKINE
- IL-4 and IL-13 signaling in allergic airway disease
- (2015) Naina Gour et al. CYTOKINE
- IL-3 synergises with basophil-derived IL-4 and IL-13 to promote the alternative activation of human monocytes
- (2015) Francesco Borriello et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- T H 2 and T H 17 inflammatory pathways are reciprocally regulated in asthma
- (2015) David F. Choy et al. Science Translational Medicine
- Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies
- (2015) Nicola A Hanania et al. THORAX
- Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial
- (2015) Christopher E Brightling et al. Lancet Respiratory Medicine
- Asthma
- (2015) Stephen T. Holgate et al. Nature Reviews Disease Primers
- Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
- (2014) Elisabeth H. Bel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
- (2014) Hector G. Ortega et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Meta-Analysis of IL-13 Polymorphisms and Pediatric Asthma Risk
- (2014) Bo Han MEDICAL SCIENCE MONITOR
- IL-13-producing BLT1-positive CD8 cells are increased in asthma and are associated with airway obstruction
- (2013) A. Dakhama et al. ALLERGY
- Sustained Suppression of IL-13 by a Vaccine Attenuates Airway Inflammation and Remodeling in Mice
- (2013) Yanbing Ma et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- IL-13 receptor α2 contributes to development of experimental allergic asthma
- (2013) Weiguo Chen et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Severe adult-onset asthma: A distinct phenotype
- (2013) Marijke Amelink et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Functional KCa3.1 Channels Regulate Steroid Insensitivity in Bronchial Smooth Muscle Cells
- (2013) L. Chachi et al. JOURNAL OF IMMUNOLOGY
- Nasal nitric oxide is a marker of poor asthma control
- (2013) Enrico Heffler et al. Journal of Breath Research
- Chitinase 3-like 1 Regulates Cellular and Tissue Responses via IL-13 Receptor α2
- (2013) Chuan Hua He et al. Cell Reports
- A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma
- (2012) Edward Piper et al. EUROPEAN RESPIRATORY JOURNAL
- IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes/macrophages
- (2012) Ashish Bhattacharjee et al. FREE RADICAL BIOLOGY AND MEDICINE
- IL-13 in asthma and allergic disease: Asthma phenotypes and targeted therapies
- (2012) Jennifer L. Ingram et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Rafael Lozano et al. LANCET
- Asthma phenotypes: the evolution from clinical to molecular approaches
- (2012) Sally E Wenzel NATURE MEDICINE
- IL-13-induced MUC5AC production and goblet cell differentiation is steroid resistant in human airway cells
- (2011) S. Kanoh et al. CLINICAL AND EXPERIMENTAL ALLERGY
- IL-13 Antibodies Influence IL-13 Clearance in Humans by Modulating Scavenger Activity of IL-13R 2
- (2011) M. T. Kasaian et al. JOURNAL OF IMMUNOLOGY
- Lebrikizumab Treatment in Adults with Asthma
- (2011) Jonathan Corren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiogenesis and lymphangiogenesis in bronchial asthma
- (2010) A. Detoraki et al. ALLERGY
- Effects of Interleukin-13 Blockade on Allergen-induced Airway Responses in Mild Atopic Asthma
- (2010) Gail M. Gauvreau et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Relationships between Severity of Chronic Rhinosinusitis and Nasal Polyposis, Asthma, and Atopy
- (2010) Aaron N. Pearlman et al. American Journal of Rhinology & Allergy
- The Interleukin 13 (IL-13) Pathway in Human Macrophages Is Modulated by MicroRNA-155 via Direct Targeting of Interleukin 13 Receptor α1 (IL13Rα1)
- (2010) Rocio T. Martinez-Nunez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Molecular Basis for Shared Cytokine Recognition Revealed in the Structure of an Unusually High Affinity Complex between IL-13 and IL-13Rα2
- (2010) Patrick J. Lupardus et al. STRUCTURE
- A phase 1 study evaluating the pharmacokinetics, safety and tolerability of repeat dosing with a human IL-13 antibody (CAT-354) in subjects with asthma
- (2010) Dave Singh et al. BMC Pulmonary Medicine
- A Novel Role of Interleukin-13 Receptor 2 in Pancreatic Cancer Invasion and Metastasis
- (2009) T. Fujisawa et al. CANCER RESEARCH
- Determinants of Exhaled Nitric Oxide in Chronic Rhinosinusitis
- (2009) Giuseppe Guida et al. CHEST
- Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects
- (2009) Aikaterini Detoraki et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Human Pharmacokinetics/Pharmacodynamics of an Interleukin-4 and Interleukin-13 Dual Antagonist in Asthma
- (2009) Elise Burmeister Getz et al. JOURNAL OF CLINICAL PHARMACOLOGY
- IL-13R 2 Membrane and Soluble Isoforms Differ in Humans and Mice
- (2009) W. Chen et al. JOURNAL OF IMMUNOLOGY
- Molecular and Structural Basis of Cytokine Receptor Pleiotropy in the Interleukin-4/13 System
- (2008) Sherry L. LaPorte et al. CELL
- Increased sputum and bronchial biopsy IL-13 expression in severe asthma
- (2008) Shironjit K. Saha et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Distinct roles for IL-13 and IL-4 via IL-13 receptor 1 and the type II IL-4 receptor in asthma pathogenesis
- (2008) A. Munitz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now